Pathophysiological Roles of Stress-Activated Protein Kinases in Pulmonary Fibrosis

• Published in: International journal of molecular sciences Vol. 22; no. 11; p. 6041
• Main Authors: Kasuya, Yoshitoshi, Kim, Jun-Dal, Hatano, Masahiko, Tatsumi, Koichiro, Matsuda, Shuichi
• Format: Journal Article
• Language: English
• Published: MDPI 03-06-2021; MDPI AG
• Subjects: c-Jun NH2-terminal kinase; idiopathic pulmonary fibrosis; p38 MAPK; Review; stress-activated protein kinases
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22116041

Idiopathic pulmonary fibrosis (IPF) is one of the most symptomatic progressive fibrotic lung diseases, in which patients have an extremely poor prognosis. Therefore, understanding the precise molecular mechanisms underlying pulmonary fibrosis is necessary for the development of new therapeutic options. Stress-activated protein kinases (SAPKs), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (p38) are ubiquitously expressed in various types of cells and activated in response to cellular environmental stresses, including inflammatory and apoptotic stimuli. Type II alveolar epithelial cells, fibroblasts, and macrophages are known to participate in the progression of pulmonary fibrosis. SAPKs can control fibrogenesis by regulating the cellular processes and molecular functions in various types of lung cells (including cells of the epithelium, interstitial connective tissue, blood vessels, and hematopoietic and lymphoid tissue), all aspects of which remain to be elucidated. We recently reported that the stepwise elevation of intrinsic p38 signaling in the lungs is correlated with a worsening severity of bleomycin-induced fibrosis, indicating an importance of this pathway in the progression of pulmonary fibrosis. In addition, a transcriptome analysis of RNA-sequencing data from this unique model demonstrated that several lines of mechanisms are involved in the pathogenesis of pulmonary fibrosis, which provides a basis for further studies. Here, we review the accumulating evidence for the spatial and temporal roles of SAPKs in pulmonary fibrosis.